^
BIOMARKER:

IDH1 mutation

i
Other names: HEL-216, HEL-S-26, Epididymis Luminal Protein 216, Isocitrate Dehydrogenase 1 (NADP+), Epididymis Secretory Protein Li 26, IDH1, Isocitrate Dehydrogenase (NADP(+)) 1, Isocitrate Dehydrogenase 1 (NADP+), Soluble




Show legend

Include preclinical:
Acute Myelogenous Leukemia
Astrocytoma
Glioma
Glioblastoma
Cholangiocarcinoma
Sarcoma
Myelodysplastic Syndrome
Oligodendroglioma
Chronic Myeloid Leukemia
Biliary Tract Cancer
Chronic Myelomonocytic Leukemia
Anaplastic Astrocytoma
Leukemia
CDIAG
PCV
IDH1 inhibitor
ivosidenib
venetoclax
lomustine
etoposide IV
cisplatin
carboplatin
carmustine
S95032
temozolomide
metformin
venetoclax + ivosidenib
temozolomide gel
olutasidenib
gemtuzumab ozogamicin
bevacizumab
NEO100
TG02
cytarabine/daunorubicin liposomal formulation
venetoclax + ABBV-621
CFI-400945
BAY1436032
olaparib
MEN1703
dasatinib
AV-GBM-1
atezolizumab
HAG + azacitidine
venetoclax + enasidenib
PRT811
lenvatinib
paclitaxel
pembrolizumab
ABBV-744
venetoclax + IACS-010759
panobinostat
pamiparib
AZD0530
bosutinib
ponatinib
decitabine
APO866
gilteritinib
cetuximab
sunitinib
NMS-173
NPI-0052
omacetaxine mepesuccinate
regorafenib
dactinomycin
romidepsin
daunorubicin
teniposide
venetoclax + sorafenib
venetoclax + gilteritinib
gemcitabine
venetoclax + midostaurin